|
Diclofenac is an effective and efficient drug used in the treatment
of the patients suffering form the pain caused due to the arthritis
and inflammation. Belonging to the NSAIF class it is much in demand.
Diclofenac achieved its first approval in July 1998.The brand
Cataflam achieved the approval from FDA on 24th August in the year
2006, while the brand Voltaren was lucky in this matter later on 6th
march in the year. Both the brands are doing good job in the markets
today. This was not all; later on the advanced form of this drug was
also approved.
On the date 18th April 2008 it was declared by the Akorn INC that
the advanced form of this drug has achieved an approval from Food
and Drug Administration. Not only this, the drug Diclofenac Sodium
Ophthalmic Solution of concentration 0.1% was also grated the
approval by the FDA.This is mainly used to treat the cataract and
also the refractive surgery patients.
The drug has been approved well in the United States (US) by the
FDA. The drug is approved by the FDA after going through many
researches, tests and reports of the clinical trails.
According to the other sales and as reported by the IMS sales
department it was found that the annual sales of this drug were
around $14 million in the year 2007.This itself proves the
popularity of this drug and its effectiveness. With such figures one
can estimate the manufacturing of this drug and also its bright
future.
|
